| 14th Feb 2017 7:00 am |
RNS |
Savolitinib PRCC Results Presentation at ASCO GU |
| 6th Feb 2017 7:00 am |
RNS |
Chi-Med to Announce 2016 Final Results |
| 1st Feb 2017 7:00 am |
RNS |
Change of Directors |
| 16th Jan 2017 10:48 am |
RNS |
Change of Directors |
| 16th Jan 2017 10:11 am |
RNS |
Change of Directors |
| 16th Jan 2017 7:30 am |
RNS |
Fruquintinib Phase I/II Clinical Data at ASCO GI |
| 16th Jan 2017 7:29 am |
RNS |
Sulfatinib Phase II Study in 2nd Line BTC in China |
| 16th Jan 2017 7:16 am |
RNS |
Fruquintinib Combination Study in 1st-Line NSCLC |
| 10th Jan 2017 7:00 am |
RNS |
Chi-Med Initiates HMPL-523 Clinical Trials |
| 30th Dec 2016 9:11 am |
RNS |
Total Voting Rights |
| 29th Dec 2016 7:40 am |
RNS |
Blocklisting Six Monthly Return |
| 20th Dec 2016 7:18 am |
RNS |
Director's Share Dealing |
| 14th Dec 2016 7:14 am |
RNS |
Director's Share Dealing |
| 6th Dec 2016 7:00 am |
RNS |
HMPL-523 Pre-clinical Data Presented at ASH |
| 30th Nov 2016 7:51 am |
RNS |
Exercise of Share Options |
| 30th Nov 2016 7:48 am |
RNS |
Total Voting Rights |
| 23rd Nov 2016 7:34 am |
RNS |
Director's Share Dealing |
| 23rd Nov 2016 7:30 am |
RNS |
Chi-Med to Present Data at the 17th WCLC |
| 23rd Nov 2016 7:08 am |
RNS |
Chi-Med to Present Data at the at the 17th WCLC |
| 14th Nov 2016 9:06 am |
RNS |
Chi-Med Presents Ph I Clinical Data for HMPL-523 |
| 1st Nov 2016 2:57 pm |
RNS |
Director's Share Dealing |
| 31st Oct 2016 7:00 am |
RNS |
Joint Venture - US$59.5m Land Compensation Payment |
| 12th Oct 2016 7:00 am |
RNS |
Director's Share Dealing |
| 9th Aug 2016 8:07 am |
RNS |
Director's Share Dealing |
| 2nd Aug 2016 8:18 am |
RNS |
Change of Non-executive Directors |
| 2nd Aug 2016 7:00 am |
RNS |
Chi-Med 2016 Interim Results |
| 1st Aug 2016 7:21 am |
RNS |
Chi-Med and AstraZeneca to Accelerate Savolitinib |
| 5th Jul 2016 7:00 am |
RNS |
Chi-Med to Announce 2016 HY Financial Results |
| 29th Jun 2016 7:00 am |
RNS |
Blocklisting Six Monthly Return |
| 20th Jun 2016 7:00 am |
RNS |
Savolitinib Global Phase II Trial Initiated |
| 15th Jun 2016 8:09 am |
RNS |
Additional Listing |
| 31st May 2016 7:00 am |
RNS |
Total Voting Rights |
| 13th May 2016 7:00 am |
RNS |
Enrollment completion of Phase III fruquintinib |
| 29th Apr 2016 7:00 am |
RNS |
Total Voting Rights |
| 27th Apr 2016 1:12 pm |
RNS |
Results of Annual General Meeting |
| 13th Apr 2016 4:23 pm |
RNS |
Exercise of Overallotment Option |
| 31st Mar 2016 7:00 am |
RNS |
Total Voting Rights |
| 29th Mar 2016 8:00 am |
RNS |
Director/PDMR Shareholding |
| 23rd Mar 2016 10:34 am |
RNS |
Holding(s) in Company |
| 22nd Mar 2016 2:00 pm |
RNS |
Closing of U.S. Public Offering of ADSs |
